RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Shorts will get smashed soon Beyond that is that persons presuming the US will welcome this sector with open arms are delusional. Just look at the politics...50/50 split, down the middle. Yes, 50 want their weed/derivatives, but the other 50 believe it to be devil worship, so couple that with the teething pains that Lemoyne correctly points out, and LABS has prime-mover advantage.
And it's lunacy to suggest the German market is a puddle. Germany and it's progressive society embraces alterative medicine in ways that the NA market does not...this is true for all Europe, so a deal with Stada doesn't just mean Germany, it means all of Europe.....Europe ain't no puddle and the fact that it will be openning up to LABS early 2021 means big time advantage.
Stada or Bain takes an equity stake by end of 2021 or in 2022.....I just hope by then our SP is reflective of our true potential.
Fladibabba has a clear motive here, as if he doesn't believe he'll get back to his average, then why not sell, plug your nose and move on? Hmmmm....wonder why not?
Lemoyne wrote: So simpleminded. Every thing is guaranteed in your head and looks so easy. Everything you mention is possible but your timeline is so short. It took 2 years for Cad market to evolve and be bottlenecked and we are finally seeing some M&A talks. It's not because cannabis is legal that banks welcome them warmly.
It's gonna take years for everything you mentioned to happen, because banks won't shell out candy to every one so quickly. M&A's happening too soon will lead to overpaying for the hype (Remember something?). You think US market will be 100% functionnal and efficient from the start? LMAO. It's gonna be chaos. The same will happen as CAD and all other markets around the world. Businesses will pop everywhere trying to gobble up market share.
And that's once the MORE act is passed. Granted it could happen within the next year, but it could also take time because of COVID and other urgent matters.
And that's not even arguing about whether LABS will be outcompetitioned or not. STADA is in the US, why wouldn't they bolster up LABS? Take an equity stake? You think they signing a contract is for Germany only? You think they are blind to US market opportunity?
Take a good look at the big picture.